BioLASCO Taiwan Co (ROCO:6662) FCF Margin % : -16.07% (As of Mar. 2024)

View and export this data going back to 2018. Start your Free Trial

What is BioLASCO Taiwan Co FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. BioLASCO Taiwan Co's Free Cash Flow for the three months ended in Mar. 2024 was NT$-7.7 Mil. BioLASCO Taiwan Co's Revenue for the three months ended in Mar. 2024 was NT$47.7 Mil. Therefore, BioLASCO Taiwan Co's FCF Margin % for the quarter that ended in Mar. 2024 was -16.07%.

As of today, BioLASCO Taiwan Co's current FCF Yield % is 4.09%.

The historical rank and industry rank for BioLASCO Taiwan Co's FCF Margin % or its related term are showing as below:

ROCO:6662' s FCF Margin % Range Over the Past 10 Years
Min: -13.68 Med: 18.87 Max: 36.44
Current: 15.29

During the past 10 years, the highest FCF Margin % of BioLASCO Taiwan Co was 36.44%. The lowest was -13.68%. And the median was 18.87%.

ROCO:6662's FCF Margin % is ranked better than
89.4% of 1038 companies
in the Biotechnology industry
Industry Median: -136.31 vs ROCO:6662: 15.29

BioLASCO Taiwan Co FCF Margin % Historical Data

The historical data trend for BioLASCO Taiwan Co's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioLASCO Taiwan Co FCF Margin % Chart

BioLASCO Taiwan Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

Get a 7-Day Free Trial

36.44

-13.68

29.21

17.13

10.51

BioLASCO Taiwan Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
FCF Margin %	Get a 7-Day Free Trial															-40.92	4.51	38.34	26.46	-16.07

Competitive Comparison of BioLASCO Taiwan Co's FCF Margin %

For the Biotechnology subindustry, BioLASCO Taiwan Co's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BioLASCO Taiwan Co's FCF Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BioLASCO Taiwan Co's FCF Margin % distribution charts can be found below:

* The bar in red indicates where BioLASCO Taiwan Co's FCF Margin % falls into.

BioLASCO Taiwan Co FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

BioLASCO Taiwan Co's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	27.829	/	264.723
	=	10.51 %

BioLASCO Taiwan Co's FCF Margin for the quarter that ended in Mar. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Mar. 2024 )	/	Revenue (Q: Mar. 2024 )
	=	-7.67	/	47.717
	=	-16.07 %

BioLASCO Taiwan Co FCF Margin % Related Terms

Thank you for viewing the detailed overview of BioLASCO Taiwan Co's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

BioLASCO Taiwan Co (ROCO:6662) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BioLASCO Taiwan Co Ltd (ROCO:6662) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

3rd Floor, 316 Chong-yang Road, Taipei, TWN, 115

Website

http://www.biolasco.com.tw

BioLASCO Taiwan Co Ltd is a biological experimental development company. The company has produced strains of laboratory rats and mice, including outbreed stocks, inbreed strains, and immunedeficient models. It offers reagent kit and equipment which include Allentown, Biomedical data system, PLAS LABS.

BioLASCO Taiwan Co (ROCO:6662) Headlines

No Headlines